AzurRx BioPharma, Inc. AZRX
Set alert
3.45 +3.45 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 34.38M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.93
- Beta
- 1.51
- Short ratio
- 0.19
- Inst. own
- 5.82%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 15, 2021
- 50-d avg
- 4.94
- 200-d avg
- 7.50
- 1y target
- 16.00
Financial health
Altman Z-Score
-9.82 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.8×
FY 2015 5y median -1.4× FY 2025
P/S 154×
FY 2015 5y median 0.0× FY 2025
P/B 0.2×
FY 2015 5y median 0.2× FY 2025
P/FCF -1.0×
FY 2015 5y median -1.7× FY 2025
EV/EBITDA 11.9×
FY 2015 5y median -1.4× FY 2025
EV/Sales 189×
FY 2015 5y median 0.0× FY 2025
FCF Yield -102.2%
FY 2015 5y median -60.3% FY 2025
Profitability
Gross Margin 0.0%
FY 2015 5y median 0.0% FY 2025
Operating Margin -19540.0%
FY 2015 5y median 0.0% FY 2025
Net Margin -18078.3%
FY 2015 5y median 0.0% FY 2025
ROE -26.3%
FY 2015 5y median -26.3% FY 2025
ROIC -19.9%
FY 2015 5y median -237.0% FY 2025
ROA -13.5%
FY 2015 5y median -170.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2015 FY 2025
Operating Income 54.7%
FY 2015 FY 2025
EPS (diluted) 22.0%
FY 2015 FY 2025
Free Cash Flow 38.1%
FY 2015 FY 2025
Financial Health
Current Ratio 0.2×
FY 2015 5y median 0.8× FY 2025
Quick Ratio 0.2×
FY 2015 5y median 0.8× FY 2025
Debt / Equity 0.1×
FY 2015 5y median 0.1× FY 2025
Net Debt / EBITDA 2.2×
FY 2015 5y median 0.0× FY 2025
Interest Coverage 14.4×
FY 2015 5y median -34.0× FY 2025
Dividends
Dividend Yield 6.0%
FY 2015 5y median 0.0% FY 2025
Payout Ratio -5.1%
FY 2015 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31